Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
J Psychopharmacol ; 24(8): 1175-81, 2010 Aug.
Article in English | MEDLINE | ID: mdl-19204062

ABSTRACT

The neural basis of generalized anxiety disorder (GAD) is poorly characterized. The effect of chronic administration (12 weeks) of paroxetine, a selective serotonin reuptake inhibitor, on N-acetylaspartate (NAA), a marker of neuronal viability, was evaluated in adults with GAD using proton magnetic resonance spectroscopic imaging ((1)H MRSI) at 1.5 T. We hypothesized that, pretreatment abnormalities in hippocampal NAA/creatine (NAA/Cr) would normalize with symptomatic improvement. Nine GAD patients (mean age = 41.7 year; 4 females) received 12 weeks of open-label paroxetine treatment, flexibly dosed up to 60 mg/day. Clinical outcome was assessed with the Hamilton Anxiety Rating Scale (HAM-A). Multislice ( 1)H MRSI scans were performed at unmedicated baseline and following 6 and 12 weeks of treatment. Ten untreated healthy volunteers (HVs) (mean age = 37.1 year; 4 females) received scans at the same intervals. All patients achieved remission (HAM-A

Subject(s)
Anxiety Disorders/drug therapy , Aspartic Acid/analogs & derivatives , Hippocampus/drug effects , Neurons/metabolism , Paroxetine/pharmacology , Selective Serotonin Reuptake Inhibitors/pharmacology , Adult , Anxiety Disorders/metabolism , Aspartic Acid/metabolism , Creatine/metabolism , Female , Hippocampus/metabolism , Humans , Male , Middle Aged , Neurons/drug effects , Paroxetine/administration & dosage , Paroxetine/adverse effects , Pilot Projects , Psychiatric Status Rating Scales , Selective Serotonin Reuptake Inhibitors/administration & dosage , Selective Serotonin Reuptake Inhibitors/adverse effects , Time Factors , Treatment Outcome
2.
Br J Cancer ; 98(4): 776-83, 2008 Feb 26.
Article in English | MEDLINE | ID: mdl-18253124

ABSTRACT

Tetrathiomolybdate (choline salt; ATN-224), a specific, high-affinity copper binder, is currently being evaluated in several phase II cancer trials. ATN-224 inhibits CuZn superoxide dismutase 1 (SOD1) leading to antiangiogenic and antitumour effects. The pharmacodynamics of tetrathiomolybdate has been followed by tracking ceruloplasmin (Cp), a biomarker for systemic copper. However, at least in mice, the inhibition of angiogenesis occurs before a measurable decrease in systemic copper is observed. Thus, the identification and characterisation of other biomarkers to follow the activity of ATN-224 in the clinic is of great interest. Here, we present the preclinical evaluation of two potential biomarkers for the activity of ATN-224: (i) SOD activity measurements in blood cells in mice and (ii) levels of endothelial progenitor cells (EPCs) in bonnet macaques treated with ATN-224. The superoxide dismutase activity in blood cells in mice is rapidly inhibited by ATN-224 treatment at doses at which angiogenesis is maximally inhibited. Furthermore, ATN-224 dosing in bonnet macaques causes a profound and reversible decrease in EPCs without significant toxicity. Thus, both SOD activity measurements and levels of EPCs may be useful biomarkers of the antiangiogenic activity of ATN-224 to be used in its clinical development.


Subject(s)
Angiogenesis Inhibitors/pharmacology , Biomarkers/metabolism , Endothelium, Vascular/drug effects , Enzyme Inhibitors/pharmacology , Molybdenum/pharmacology , Superoxide Dismutase/antagonists & inhibitors , Animals , Blood Cells/drug effects , Blood Cells/metabolism , Collagen/metabolism , Copper/metabolism , Drug Combinations , Female , Laminin/metabolism , Macaca radiata , Male , Mice , Mice, Inbred BALB C , Mice, Nude , Proteoglycans/metabolism , Stem Cells/drug effects , Superoxide Dismutase/metabolism , Superoxide Dismutase-1
3.
Psychoneuroendocrinology ; 27(6): 651-60, 2002 Aug.
Article in English | MEDLINE | ID: mdl-12084658

ABSTRACT

The two neuropeptides corticotropin-releasing-factor (CRF) and oxytocin (OT) may produce opposing behavioral effects - elevations of the former have been associated with anxiety and social vigilance and reductions of the latter with reduced social affiliation. We sought to test the hypothesis that, within the primate macaque genus, the more gregarious, affiliative, and affectively stable bonnet species (Macaca radiata) would exhibit lower cerebrospinal fluid (CSF) CRF and higher CSF OT concentrations in comparison to its close relative, the temperamentally volatile and socially distant pigtail (Macaca nemestrina). Cisternal CSF samples were obtained from young adult male and female pigtail and bonnet macaques, and CRF and OT concentrations were measured by radioimmunoassay. Pigtail macaques exhibited significantly higher concentrations of CSF CRF and significant lower concentrations of CSF OT than bonnet macaques. Results were not attributable to age or sex differences in group composition. When included together in a multiple regression, CRF and OT showed a multiple R of 0.76, accounting for more than half of the species variance. Although species differences in the bioeffectiveness of these peptides may possibly confound the observed biobehavioral relationships, in the absence of any existing data to that effect, the current findings appear in accordance with the hypothesis and consistent with previously reported species-typical behaviors observed in these macaques.


Subject(s)
Corticotropin-Releasing Hormone/cerebrospinal fluid , Macaca nemestrina/cerebrospinal fluid , Macaca radiata/cerebrospinal fluid , Oxytocin/cerebrospinal fluid , Animals , Female , Male , Reference Values , Regression Analysis , Species Specificity
SELECTION OF CITATIONS
SEARCH DETAIL
...